This supplement contains the record of invited presentations from the International Congress on Neonatal Jaundice held in Hong Kong in March 2001. These presentations were made by experts representing several disciplines, including both clinical and basic research, who have contributed to our recent understanding of bilirubin metabolism, neonatal hyperbilirubinemia, and kernicterus. In addition, newer approaches to identification of infants at risk, as well as approaches to their management, were discussed. The advances described encompass those that occurred in the interval of 42 years since the first International Kernicterus Symposium, which was held in conjunction with the Ninth International Congress of Pediatrics in Montreal in 1959.
Reports at that earlier meeting had, like those at the Hong Kong meeting, been made by invited experts responsible for an earlier decade of progress in understanding bilirubin metabolism and kernicterus. At that 1959 meeting, knowledge concerning the pathogenesis of the clinical and pathological entity of kernicterus had increased a great deal between 1950 and 1959. The newer information discussed at the meeting included the transitional metabolism of bilirubin in the neonate, particularly the development of the bilirubin-conjugating system. The latter was defined as central to the problem of neonatal jaundice and hyperbilirubinemia. In Rh erythroblastosis fetalis, a quantitative relationship had been demonstrated between serum bilirubin levels and the risk of kernicterus. Further, there was recognition that the yellow staining of the brain in kernicterus was due to deposition of unconjugated, indirect-reacting bilirubin. The important role of albumin binding of bilirubin was recognized. During that 10-year period antedating the 1959 conference, there was also proof of the actual toxicity of bilirubin, and the term ''bilirubin encephalopathy'' began to be used, though the old term ''kernicterus'' persisted. There was enormous interest in the subject of the conference and in the new information brought forth. This might have been expected because hyperbilirubinemia was considered to be the most common problem encountered in the term neonate even though its main risk, kernicterus, was relatively rare. There was an unexpectedly large audience attending the conference and many favorable comments were received. Because of the numerous requests for abstracts of the reports at that meeting, it was decided that the material should be published, and both the chairman of the program committee and the General Secretary of the Congress supported the concept of a report, which was later published (Sass-Kortsák A, editor. Kernicterus. Report based on a symposium held at the IX International Congress of Paediatrics, Montreal, July 1959. Toronto, Canada: University of Toronto Press; 1961).
Between that 1959 meeting and the 2001 symposium in Hong Kong, there have been great strides in our understanding of neonatal jaundice, including the role of genetic disorders, breastfeeding, the interaction of increased bilirubin production and decreased bilirubin elimination in the transitional period after birth, and the use of metalloporphyrins to block heme oxygenase and thus the formation of bilirubin. That 1959 meeting antedated the use of Rhogam to prevent Rh erythroblastosis. Although a report on the usefulness of phototherapy in neonatal jaundice had been published in 1958, there was not yet widespread application of this form of therapy to prevent and control hyperbilirubinemia. It also antedated the use of the auditory brainstem response to define bilirubin-induced auditory neuropathy. The use of breath analysis of carbon monoxide to identify hemolysis and increased bilirubin production had only been suggested recently, and generally was not available to the clinician.
Between the two conferences, there had initially been a remarkable decrease in the occurrence of kernicterus in most of the Western world. Rh erythroblastosis had been virtually eradicated and phototherapy had successfully reduced the need for exchange transfusions. Young physicians rarely, if ever, saw Rh erythroblastosis or kernicterus. During this period, formula feeding was the norm and infants remained under observation in the nursery for several days. This allowed for evaluation of the usual rise in bilirubin as well as the quality of feeding. Beginning in the early 1980s, the control of hyperbilirubinemia had been so successful that many young physicians doubted the toxicity of bilirubin and the risk of kernicterus for term infants. Coupled with this were two other major changes in newborn care -a marked increase in breastfeeding to about 65% of new mothers and a shortened nursery stay, sometimes as limited as 12 to 24 hours.
Beginning in the mid-1980s, and increasingly in the 1990s, cases of kernicterus in apparently healthy term newborns began to appear hyperbilirubinemia, such as the role of glucose-6-phosphate dehydrogenase deficiency and Gilbert's disease. The role played by inadequate breastfeeding in the development of neonatal hyperbilirubinemia was also discussed. The recent collaborative study, using newer approaches for identification of infants at risk for development of hyperbilirubinemia, was described in detail, including techniques for identification of increased bilirubin production (using breath analysis of carbon monoxide) and use of early hour-specific bilirubin measurements. The meeting fostered discussion and exchange of ideas among investigators and clinicians, and this publication should help the reader to appreciate advances made during the past 42 years throughout the world in our understanding of neonatal jaundice, as well as new approaches to its management.
